Close

Credit Suisse Assesses St. Jude Medical (STJ) Risk; Says Product Removal Unlikely But Could Be Grounds for Abbott to Exit or Lower Bid

Go back to Credit Suisse Assesses St. Jude Medical (STJ) Risk; Says Product Removal Unlikely But Could Be Grounds for Abbott to Exit or Lower Bid

St. Jude Medical (STJ) puts active on Muddy Waters short report

August 25, 2016 11:31 AM EDT

St. Jude Medical (NYSE: STJ) September 75 and 80 puts are active on total put volume of 7,600 puts (129 calls) on news of Muddy Waters short report. September put option implied volatility is at 33, October is at 36; compared to its 52-week range of 12 to 37.

... More

Abbott (ABT) Lower as Merger Partner St. Jude (STJ) Hit with Short Report

August 25, 2016 10:58 AM EDT

Abbott (NYSE: ABT), which is in a deal to acquire St. Jude Medical, Inc (NYSE: STJ), is weaker as Muddy Waters went short the stock.

ABT is down 0.7%, while STJ is down 2.6%.

... More

St. Jude Medical (STJ) Mentioned as Short at Muddy Waters

August 25, 2016 10:53 AM EDT

(Updated - August 25, 2016 10:57 AM EDT)

St. Jude Medical (NYSE: STJ) was mentioned cautiously by short seller Muddy Waters Research. The report suggests that close to half of STJs revenue could disappear for approximately two years as the... More